Bausch Health Companies Inc BHC

NYS: BHC | ISIN: CA0717341071   31/05/2024
6,560 USD (+4,29%)
(+4,29%)   31/05/2024

5 oktober 2023 · Thinking about trading options or stock in Tesla, Palantir Technologies, Bausch Health Companies, Alphabet Inc, or Shell? · Persbericht

26 september 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NYSE: BHC) · Persbericht

10 september 2023 · Bausch Health Companies Inc. (BHC) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf · Persbericht

8 september 2023 · BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit · Persbericht

2 september 2023 · Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of September 25, 2023 Deadline in Securities Fraud Class Action against of Bausch Health Companies Inc. and Urges Investors with Substantial Losses to Contact the Firm · Persbericht

25 augustus 2023 · BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit · Persbericht

24 augustus 2023 · Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm · Persbericht

14 augustus 2023 · Bausch Health Companies Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

12 augustus 2023 · BHC INVESTOR NOTICE: Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit · Persbericht

6 augustus 2023 · BHC CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Bausch Health Companies Inc. (BHC) · Persbericht

31 mei 2023 · OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease · Persbericht

12 oktober 2022 · Salix Pharmaceuticals Releases Liver Health Annual Trends Report Underscoring Challenges In Caring For Growing Chronic Liver Disease And Cirrhotic Patient Population · Persbericht

5 oktober 2022 · Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022 · Persbericht

3 oktober 2022 · Salix Pharmaceuticals Applauds Implementation Of K76.82 - A New Icd-10 Code For Hepatic Encephalopathy · Persbericht

28 september 2022 · Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations · Persbericht

14 september 2022 · Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations · Persbericht

9 september 2022 · Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin · Persbericht

8 september 2022 · Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations · Persbericht

31 augustus 2022 · Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes · Persbericht

22 augustus 2022 · Bausch Health Continuing Process Toward Separating Bausch + Lomb · Persbericht

Mijn selecties